MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Nov 20, 2025 · CIK: 1878313
Sentiment: neutral
Topics: filing, corporate-update
TL;DR
MAIA Bio filed an 8-K on Nov 20, 2025, with updates.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on November 20, 2025, reporting other events and financial statements. The company, incorporated in Delaware, has its principal executive offices in Chicago, IL.
Why It Matters
This filing indicates MAIA Biotechnology, Inc. is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing with no immediate indication of significant financial distress or positive development.
Key Numbers
- 001-41455 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- November 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Address of principal executive offices
- 001-41455 (commission_file_number) — SEC File Number
FAQ
What specific 'Other Events' are being reported by MAIA Biotechnology, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item, but the specific details of these events are not provided in the provided text snippet.
What is the nature of the 'Financial Statements and Exhibits' being filed?
The filing lists 'Financial Statements and Exhibits' as an item, but the content or type of these statements and exhibits is not detailed in the provided text.
When was MAIA Biotechnology, Inc. incorporated?
MAIA Biotechnology, Inc. was incorporated in Delaware.
What is the principal business address of MAIA Biotechnology, Inc.?
The principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the telephone number for MAIA Biotechnology, Inc.?
The registrant's telephone number, including area code, is (312) 416-8592.
Filing Stats: 775 words · 3 min read · ~3 pages · Grade level 14.6 · Accepted 2025-11-20 09:00:27
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- 0001493152-25-024402.txt ( ) — 240KB
- maia-20251120.xsd (EX-101.SCH) — 3KB
- maia-20251120_lab.xml (EX-101.LAB) — 33KB
- maia-20251120_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 20, 2025 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer 3